Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Early Targeted Ibuprofene Treatment of Patent Ductus Arteriosus (PDA) on Long Term Neurodevelopmental Outcome in Very Premature Infants (TRIOCAPI)

NCT01630278 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01630278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01630278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Early Targeted Ibuprofene Treatment of Patent Ductus Arteriosus (PDA) on Long Term Neurodevelopmental Outcome in Very Premature Infants (TRIOCAPI)
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2019
Enrollment
363 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus